trial
as of 2026-07-01Evaluating the Cost Effectiveness of ISTDP: A Quasi Experimental Study
NCTId NCT01924715
at a glance
Phase — · Completed
Enrollment 1,082 (actual)
Sponsored by Nova Scotia Health Authority
Primary completion 2009-03
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
1,082 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2008-01
Primary completion
2009-03
Eligibility
ALL · 12 Years · 90 Years
Interventions & indications
Sponsors
Nova Scotia Health AuthorityLead Sponsor
Investigators
1
Allan A Abbass, MD, FRCPCPrincipal Investigator
Sites
1 total
Halifax, Canada
Facts & assertions
4 sourced
Enrollment
1,082
Phase
NA
Primary Completion Date
2009-03
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
company
indication
investigator